Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d
CA 2401665 A1 · Owner: Stacker, Steven · Inventors: Achen, Marc; Stacker, Steven
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for treating and alleviating melanomas and various cancers characterized by the expression of VEGF-D by the tumor the method comprising , screening to find an organism with tumor cells expressing VEGF-D and administering an effective amount of a VEGF-D antagonist to prevent binding of VEGF-D; methods for screening for neoplastic diseases where detection of VEGF-, D on or in cells such as tumor cells blood vessel endothelial cells, lymph vessel endothelial cells, and/or cells with potential neoplastic growth indicates neoplastic disease; a method for promoting and maintaining vascularization of normal tissue in an organism by administering VEGF-D or a fragment or analog …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 2, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 2, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 2, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.